Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

The EHA Research Roadmap: Malignant Lymphoid Diseases

Dreyling, M. ; Jerkeman, M. LU and Salles, G. (2022) In HemaSphere 6(6). p.726-726
Abstract
In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research1 iming to highlight achievements in the diagnostics and treatment of blood disorders and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology. Each section was coordinated by 1 to 2 section editors who were leading international experts in the field. In the 5 years that have followed, advances in the field of hematology have been plentiful. As such, EHA is pleased to present an updated Research Roadmap, now including 11 sections, each of which will be published separately. The updated EHA Research Roadmap identifies the most urgent... (More)
In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research1 iming to highlight achievements in the diagnostics and treatment of blood disorders and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology. Each section was coordinated by 1 to 2 section editors who were leading international experts in the field. In the 5 years that have followed, advances in the field of hematology have been plentiful. As such, EHA is pleased to present an updated Research Roadmap, now including 11 sections, each of which will be published separately. The updated EHA Research Roadmap identifies the most urgent priorities in hematology research and clinical science, therefore supporting a more informed, focused, and ideally a more funded future for European hematology research. The 11 EHA Research Roadmap sections include Normal Hematopoiesis; Malignant Lymphoid Diseases; Malignant Myeloid Diseases; Anemias and Related Diseases; Platelet Disorders; Blood Coagulation and Hemostatic Disorders; Transfusion Medicine; Infections in Hematology; Hematopoietic Stem Cell Transplantation; CAR-T and Other Cellbased Immune Therapies; and Gene Therapy. © 2022 Wolters Kluwer Health. All rights reserved. (Less)
Please use this url to cite or link to this publication:
author
; and
author collaboration
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
HemaSphere
volume
6
issue
6
pages
726 - 726
publisher
Wolters Kluwer
external identifiers
  • scopus:85131642961
  • pmid:35620592
ISSN
2572-9241
DOI
10.1097/HS9.0000000000000726
language
English
LU publication?
yes
id
7ab09f0d-de09-4389-8527-aa7f38b70dee
date added to LUP
2022-09-14 13:42:34
date last changed
2022-09-15 03:00:02
@article{7ab09f0d-de09-4389-8527-aa7f38b70dee,
  abstract     = {{In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research1 iming to highlight achievements in the diagnostics and treatment of blood disorders and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology. Each section was coordinated by 1 to 2 section editors who were leading international experts in the field. In the 5 years that have followed, advances in the field of hematology have been plentiful. As such, EHA is pleased to present an updated Research Roadmap, now including 11 sections, each of which will be published separately. The updated EHA Research Roadmap identifies the most urgent priorities in hematology research and clinical science, therefore supporting a more informed, focused, and ideally a more funded future for European hematology research. The 11 EHA Research Roadmap sections include Normal Hematopoiesis; Malignant Lymphoid Diseases; Malignant Myeloid Diseases; Anemias and Related Diseases; Platelet Disorders; Blood Coagulation and Hemostatic Disorders; Transfusion Medicine; Infections in Hematology; Hematopoietic Stem Cell Transplantation; CAR-T and Other Cellbased Immune Therapies; and Gene Therapy. © 2022 Wolters Kluwer Health. All rights reserved.}},
  author       = {{Dreyling, M. and Jerkeman, M. and Salles, G.}},
  issn         = {{2572-9241}},
  language     = {{eng}},
  number       = {{6}},
  pages        = {{726--726}},
  publisher    = {{Wolters Kluwer}},
  series       = {{HemaSphere}},
  title        = {{The EHA Research Roadmap: Malignant Lymphoid Diseases}},
  url          = {{http://dx.doi.org/10.1097/HS9.0000000000000726}},
  doi          = {{10.1097/HS9.0000000000000726}},
  volume       = {{6}},
  year         = {{2022}},
}